-
Je něco špatně v tomto záznamu ?
TOR1AIP2 as a candidate gene for dystonia-hemichorea/hemiballism
E. Kafantari, VJ. Hernandez, J. Necpál, M. Leonidou, R. Baureder, C. Hedberg-Oldfors, R. Jech, M. Zech, TU. Schwartz, A. Puschmann
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
- MeSH
- chorea * genetika MeSH
- dospělí MeSH
- dyskineze * genetika MeSH
- dystonické poruchy * genetika MeSH
- dystonie * genetika MeSH
- lidé středního věku MeSH
- lidé MeSH
- molekulární chaperony * genetika MeSH
- rodokmen MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Dystonia is a movement disorder characterized by genetic and clinical heterogeneity. A recurring p.(Glu303del)-deletion in TOR1A is a well-established cause for DYT-TOR1A (DYT1), an autosomal dominant early-onset isolated dystonia. TOR1A encodes TorsinA, an AAA + ATPase located in the nuclear envelope. By whole exome analyses of a family with a novel dystonia-hemichorea-/hemiballism phenotype, we identified a TOR1AIP2 NM_001199260.2 c.1234A > G p.(Arg412Gly) variant. The variant is very rare in databases and was absent from whole exome data from >1000 dystonia patients. TOR1AIP2 encodes LULL1, a transmembrane protein that activates TorsinA, and correct interaction between TorsinA and LULL1 is essential for proper nuclear envelope architecture. The p.(Arg412Gly) variant disrupts the binding interface between TorsinA and LULL1 around p.Arg412; this same interface is also impaired in DYT1. Functional analyses via a co-purification assay revealed that interaction between TorsinA-LULL1Arg412Gly is weaker than the wild-type interaction, and that it resembles the situation in DYT1 (TorsinAΔE303-LULL1). A second family with milder dystonia, hemichorea, and stereotypic leg flexion during gait and a TOR1AIP2 p.(Gln338His) variant was identified. The clinical phenotype of both families shared proximal arm movements, and flutter in facial musculature. Expressivity of the movement disorder symptoms was variable. Several proteins in the nuclear envelope have been implicated in various forms of neurodevelopmental disorders with dystonia. Taken together, our findings suggest TOR1AIP2 as a new candidate gene implicated in a complex hereditary movement disorder with dystonia and hemichorea/hemiballism.
2nd Department of Neurology Faculty of Medicine Comenius University Bratislava Slovakia
Department of Biology Massachusetts Institute of Technology Cambridge MA USA
Department of Neurology Zvolen Hospital Zvolen Slovakia
Institute of Advanced Study Technical University of Munich Garching Germany
Institute of Human Genetics School of Medicine Technical University of Munich Munich Germany
Institute of Neurogenomics Helmholtz Zentrum München Munich Germany
Lund University Skåne University Hospital Department of Clinical Sciences Lund Neurology Lund Sweden
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25015918
- 003
- CZ-PrNML
- 005
- 20250731091345.0
- 007
- ta
- 008
- 250708e20250311enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.parkreldis.2025.107781 $2 doi
- 035 __
- $a (PubMed)40088780
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Kafantari, Efthymia $u Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Neurology, Lund, Sweden. Electronic address: Efthymia.Kafantari@med.lu.se
- 245 10
- $a TOR1AIP2 as a candidate gene for dystonia-hemichorea/hemiballism / $c E. Kafantari, VJ. Hernandez, J. Necpál, M. Leonidou, R. Baureder, C. Hedberg-Oldfors, R. Jech, M. Zech, TU. Schwartz, A. Puschmann
- 520 9_
- $a Dystonia is a movement disorder characterized by genetic and clinical heterogeneity. A recurring p.(Glu303del)-deletion in TOR1A is a well-established cause for DYT-TOR1A (DYT1), an autosomal dominant early-onset isolated dystonia. TOR1A encodes TorsinA, an AAA + ATPase located in the nuclear envelope. By whole exome analyses of a family with a novel dystonia-hemichorea-/hemiballism phenotype, we identified a TOR1AIP2 NM_001199260.2 c.1234A > G p.(Arg412Gly) variant. The variant is very rare in databases and was absent from whole exome data from >1000 dystonia patients. TOR1AIP2 encodes LULL1, a transmembrane protein that activates TorsinA, and correct interaction between TorsinA and LULL1 is essential for proper nuclear envelope architecture. The p.(Arg412Gly) variant disrupts the binding interface between TorsinA and LULL1 around p.Arg412; this same interface is also impaired in DYT1. Functional analyses via a co-purification assay revealed that interaction between TorsinA-LULL1Arg412Gly is weaker than the wild-type interaction, and that it resembles the situation in DYT1 (TorsinAΔE303-LULL1). A second family with milder dystonia, hemichorea, and stereotypic leg flexion during gait and a TOR1AIP2 p.(Gln338His) variant was identified. The clinical phenotype of both families shared proximal arm movements, and flutter in facial musculature. Expressivity of the movement disorder symptoms was variable. Several proteins in the nuclear envelope have been implicated in various forms of neurodevelopmental disorders with dystonia. Taken together, our findings suggest TOR1AIP2 as a new candidate gene implicated in a complex hereditary movement disorder with dystonia and hemichorea/hemiballism.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a molekulární chaperony $x genetika $7 D018832
- 650 12
- $a chorea $x genetika $7 D002819
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a rodokmen $7 D010375
- 650 12
- $a dystonické poruchy $x genetika $7 D020821
- 650 12
- $a dystonie $x genetika $7 D004421
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a dyskineze $x genetika $7 D020820
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hernandez, Victoria J $u Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA
- 700 1_
- $a Necpál, Ján $u 2nd Department of Neurology, Faculty of Medicine, Comenius University, Bratislava, Slovakia; Department of Neurology, Zvolen Hospital, Zvolen, Slovakia
- 700 1_
- $a Leonidou, Marina $u Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Neurology, Lund, Sweden
- 700 1_
- $a Baureder, Regina $u Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Clinical Neurophysiology, Lund, Sweden
- 700 1_
- $a Hedberg-Oldfors, Carola $u Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
- 700 1_
- $a Jech, Robert $u Department of Neurology, Charles University in Prague, 1st Faculty of Medicine and General University Hospital in Prague, 121 08, Prague, Czech Republic
- 700 1_
- $a Zech, Michael $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany; Institute of Human Genetics, School of Medicine, Technical University of Munich, Munich, Germany; Institute of Advanced Study, Technical University of Munich, Garching, Germany
- 700 1_
- $a Schwartz, Thomas U $u Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA
- 700 1_
- $a Puschmann, Andreas $u Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Neurology, Lund, Sweden; SciLifeLab National Research Infrastructure, Sweden
- 773 0_
- $w MED00006198 $t Parkinsonism & related disorders $x 1873-5126 $g Roč. 134 (20250311), s. 107781
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40088780 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731091340 $b ABA008
- 999 __
- $a ok $b bmc $g 2366631 $s 1253043
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 134 $c - $d 107781 $e 20250311 $i 1873-5126 $m Parkinsonism & related disorders $n Parkinsonism Relat Disord $x MED00006198
- LZP __
- $a Pubmed-20250708